2m 2m 2m 2m 2m 2m 2m
EVOLUS (EOLS)
NASDAQ
$7.41+$0.005 (+0.07%)
Price as of Oct 22, 2026 7:56 PM EDT- $488.8MMarket Cap
- 8.50%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
EVOLUS (EOLS)
$7.41+$0.005 (+0.07%)
EOLS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.40 | ||
Change | +$0.03 (+0.41%) | ||
Open | $7.37 | ||
High | $7.43 | ||
Low | $7.27 | ||
Previous Close | $7.37 | ||
Volume | 912,577 | ||
30-Day Average Volume | 711,667 | ||
1-Week Change | 2.49% | ||
1-Month Change | -7.38% | ||
1-Year Change | 8.50% | ||
3-Year Change | -5.25% | ||
5-Year Change | -8.07% | ||
Fundamentals | |||
Shares Outstanding | 66.1M | ||
Total Assets | $248.0M | ||
Market Cap | $488.8M | ||
Enterprise Value | $600.3M | ||
Period: QTR TTM FY | |||
Revenue | $83.3M | ||
Net Income | -$8.1M | ||
Free Cash Flow | -$3.6M | ||
EBIT | -$8.2M | ||
EBITDA | -$5.9M | ||
Net Working Capital | $68.8M | ||
EPS | -$0.12 | ||
Enterprise Value/EBITDA | -102 | ||
Enterprise Value/Revenue | 7 | ||
P/B | -16 | ||
P/E | -62 | ||
PEG | -2 | ||
Price/Free Cash Flow | -134 | ||
Price/Operating Cash Flow | -136 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue